Methylfolate vs Folic Acid: How to Choose

What are methylfolate and folic acid?

Methylfolate, also called 5-MTHF or L-methylfolate, is the main form of folate in blood. Folic acid is a stable, manufactured form of folate that the body converts before use.

For women who could become pregnant, folic acid has the prevention evidence. It is the only form of folate shown in trials to prevent neural-tube defects, birth defects of the brain and spine that form in the first weeks of pregnancy. The Centers for Disease Control and Prevention recommends 400 mcg of folic acid a day, and the US Preventive Services Task Force recommends 400 to 800 mcg. A product with 400 mcg of folic acid meets both recommendations.

If pregnancy is not part of the decision, either form can raise blood folate. Methylfolate, also sold as 5-MTHF or L-methylfolate, sometimes raises it more, but that has not established a better health outcome.

For daily amounts, food sources, pregnancy guidance, and the other forms, see our folate guide.

Methylfolate and folic acid at a glance

Pregnancy evidence breaks the tie

For women who could become pregnant, folic acid is the only form backed by prevention trials.

A 1991 trial in women who had already had an affected pregnancy found that 4 mg of folic acid a day reduced recurrence by 72 percent. A 1992 Hungarian trial of a multivitamin containing 800 mcg of folic acid found six defects in the comparison group and none in the vitamin group. A Cochrane review pooling five trials found about a 69 percent lower risk with folic acid.

No methylfolate trial has shown the same prevention outcome. The three recent pregnancy biomarker comparisons enrolled women at eight weeks or later, after the neural tube had closed, and measured blood markers rather than birth defects.

A 2025 review points the other way but does not settle the question. Its report of fewer miscarriages and birth defects with methylfolate came from two small Chinese-language trials that compared 400 mcg of methylfolate with 800 mcg of folic acid; one of the trials was not blinded, so women and researchers knew which form they received. The authors called the evidence limited and asked for better trials. A pooled report of birth defects does not establish that methylfolate prevents neural-tube defects specifically; it does not replace the direct prevention evidence for folic acid.

A direct 2015 form comparison^[1] enrolled 220 women with at least three previous miscarriages, starting 1 mg/day of either form at least eight weeks before conception. Among the 135 who became pregnant, ongoing pregnancy at 20 weeks occurred in 36 of 69 taking methylfolate and 27 of 66 taking folic acid; the authors found no significant difference. Higher folate levels with methylfolate therefore did not establish a better pregnancy outcome. Some women were excluded after the groups were assigned, which can weaken the comparison. Other treatments could also have affected pregnancy outcomes, making it harder to isolate the folate form’s contribution. Too few women shared each genetic variant to draw dependable conclusions about variants.

Blood markers do not establish a universal winner

Most form comparisons measure folate in blood rather than health outcomes, including the pregnancy studies below.

Blood folate

At about 100 mcg a day, a 2002 trial found that both forms raised blood folate about equally. At about 400 mcg, a 2006 trial found a larger rise in red-blood-cell folate, a longer-term measure, with methylfolate. In a 2026 trial of 110 pregnant women^[2], daily doses of 1,100 mcg methylfolate glucosamine salt and 600 mcg folic acid raised red-blood-cell folate similarly over 12 weeks. The different weights supplied the same number of folate molecules: the salt includes an attached partner that adds weight. Methylfolate initially appeared to raise folate more in the liquid part of blood, but that difference was no longer statistically clear after accounting for starting levels. The biomarker evidence therefore does not support a universal winner.

Common MTHFR variants do not rule out folic acid

MTHFR is a gene involved in folate processing, and many people carry a common variant. Products often use that fact to argue that you need methylfolate. In a large trial, people with the variant had lower blood folate but still responded to folic acid. The CDC says common MTHFR variants are not a reason to avoid folic acid or change the 400 mcg recommendation.

Unmetabolized folic acid

When folic acid enters the body faster than it is converted, some can remain unchanged in blood. Methylfolate does not add this unmetabolized folic acid. Women taking methylfolate had lower levels in the 2024 and 2026 pregnancy trials, but those trials did not show that the lower level improved health for the woman or baby. Harm has not been confirmed at the recommended 400 mcg of folic acid a day.

Read the label

• DFE is a label conversion, not the form amount. DFE means dietary folate equivalents and adjusts for differences in absorption. A capsule containing 400 mcg of folic acid is listed as 667 mcg DFE when taken with food.
• Methylfolate labels can hide the form amount. The maker may use a conversion factor up to 1.7. One product says "400 mcg" on the front and lists only 400 mcg DFE on the Supplement Facts label. Without the maker's factor, you cannot tell the exact micrograms of methylfolate.
• For pregnancy, count the folic acid. Look for "as folic acid" and the micrograms in parentheses. A prenatal with only methylfolate does not carry the prevention evidence.
• Do not treat milligrams like micrograms. A 15 mg L-methylfolate capsule contains 15,000 mcg of methylfolate. That dose comes from depression-treatment research, not routine nutrition.
• The upper limit applies to folic acid. The official upper limit from the National Academies is 1,000 mcg a day of folic acid from supplements and fortified foods. Count the folic acid amount, not DFE. The United States has not set a separate limit for methylfolate; that does not make any amount safe. Clinician-supervised treatment doses are handled separately.

Include the foods as well as the bottle in that form comparison. An enriched-grain product may already supply folic acid even if your supplement uses methylfolate. Switching the capsule does not remove that food contribution. Count the declared folic-acid amount separately from total DFE when reviewing overlap. ^[3], ^[4]

Who should let a doctor choose?

Let a doctor choose the form and amount when your pregnancy history, symptoms, or medicines make this more than a routine nutrition decision.

• Women who have had a pregnancy affected by a neural-tube defect. The recurrence trial used 4 mg of folic acid a day, ten times the standard 400 mcg amount. A doctor should choose and prescribe the dose for a future pregnancy.
• People with possible or confirmed B12 deficiency, anemia with large red blood cells, numbness, or balance problems. Folic acid can correct the anemia of B12 deficiency while nerve damage continues; get B12 checked before taking either form.
• People taking methotrexate, trimethoprim, pyrimethamine, sulfasalazine, or an antiseizure medicine. Folate can change how these drugs work, and the form and timing depend on the drug.
• Anyone considering milligram-dose L-methylfolate for mood. That is a treatment decision, not a supplement swap.

The bottom line

For women who could become pregnant, choose a product that clearly lists 400 to 800 mcg of folic acid: it has the evidence for preventing neural-tube defects. A mix of folic acid and methylfolate can fit if the folic acid amount is clear.

If pregnancy is not part of the decision, either form can raise blood folate. For methylfolate, choose a label that shows the form's actual micrograms rather than DFE alone. “Active” does not establish better health outcomes, and a common MTHFR variant does not by itself require the more expensive form. Treatment doses need a clinical reason and plan.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly